Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization

Cancer

Volumn 83, Issue 2, 1998, Pages 360-366

  Ishino, Shinsuke ^a   Hashimoto, Naoya ^a   Fushiki, Shinji ^a   Date, Kousei ^a   Mori, Toshiki ^a   Fujimoto, Masahito ^b   Nakagawa, Yoshio ^a   Ueda, Satoshi ^a   Abe, Tatsuo ^a   Inazawa, Johji ^a,c  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Imperial Gift Foundation Inc   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Chromosome arm 1p; Double target fluorescent in situ hybridization; Malignant progression; Meningioma

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOME 1P; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MENINGIOMA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 1; DISEASE PROGRESSION; FEMALE; GENE DELETION; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; PROGNOSIS;

EID: 0032527701     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980715)83:2<360::AID-CNCR21>3.0.CO;2-Q     Document Type: Article

References (22)

1. The committee of brain tumor registry of Japan. General rules for clinical and pathological studies on brain tumors. Tokyo: Kanehara & Company, LTD., 1995:9-11.
2. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumors of the central nervous system. Berlin: Springer-Verlag, Inc., 1993:33-42.
3. Mahmood A, Caccamo DV, Tomecek FJ, Malik GM. Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 1993;33:955-63.
4. Jääskeläinen J, Haltia M, Servo A. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 1986;25:233-42.
5. Maier H, Ofner D, Hittmair A, Kitz HK, Budka H. Classic, atypical, and anaplastic meningioma. J Neurosurg 1992;77: 616-23.
6. Brodeur GM, Fong CT. Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet 1989;41:153-74.
7. Bigner SH, Mark J, Friedman HS, Biegel JA, Bigner DD. Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet Cytogenet 1988;30:91-101.
8. Hashimoto N, Ichikawa D, Arakawa Y, Date K, Ueda S, Nakagawa Y, et al. Frequent deletions of material from chromosome arm 1p in oligodendroglial tumors revealed by double-target fluorescence in situ hybridization and microsatellite analysis. Genes Chromosom Cancer 1995;14:295-300.
9. Bello MJ, Leone PE, Nebreda P, de Campos JM, Kusak HE, Vaquero J, et al. Allelic status of chromosome 1 in neoplasms of the nervous system. Cancer Genet Cytogenet 1995; 83:160-4.
10. Bello MJ, Campos JM, Kusak E, Vaquero J, Sarasa JL, Pestaña A, et al. Allelic loss at 1p is associated with tumor progression of meningiomas. Gene Chromosome Cancer 1994;9:296-8.
11. Simon M, von Deimling A, Larson JJ, Wellenreuther R, Kaskel P. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 1995;55:4696-701.
12. Cooke HJ, Hindley J. Cloning of human satellite 3 DNA: different components are on different chromosomes. Nucleic Acids Res 1979;6:3177-97.
13. Ariyama T, Inazawa J, Ezaki T, Nakamura Y, Horii A, Abe T. High-resolution cytogenetic mapping of the short arm of chromosome 1 with newly isolated 411 cosmid makers by fluorescence in situ hybridization: the precise order of 18 markers on 1p36.1 on prophase chromosomes and "stretched" DNAs. Genomics 1995;25:114-23.
14. Inazawa J, Ariyama T, Abe T. Physical ordering of three polymorphic DNA markers spanning the regions containing a tumor suppressor gene of renal cell carcinoma by three-color fluorescence in situ hybridization. Jpn J Cancer Res 1992;83:1248-52.
15. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957; 20:22-39.
16. Mittelman F, Kaneko Y, Berger R. Report of the committee on chromosome changes in neoplasia. In: Cuticchia AJ, Chipperfield MA, Foster, PA, editors. Human gene mapping 1995: a compendium. Baltimore: Johns Hopkins University Press, 1996:1332-50.
17. Dumanski JP, Rouleau GA, Nordenskjold M, Collins VP. Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res 1990;50:5863-7.
18. Ruttledge MH, Xie YG, Han FY, Peyrard M, Collins VP, Nordenskjold M, et al. Deletions of chromosome 22 in sporadic meningioma. Genes Chromosom Cancer 1994;10: 172-30.
19. Akagi K, Kurahashi H, Arita N, Hayakawa T, Monden M, Mori T, et al. Deletion mapping of the long arm of chromosome 22 in human meningiomas. Int J Cancer 1995;60:178-82.
20. Ruttledge MH, Sarrazin J, Rangaratham S, Phelan CM, Twist E, Merel P, et al. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 1994;6:180-4.
21. Jimenéz-Lara AM, Rey JA, Bello MJ, de Campos JM, Vaquero J, Kusak ME, et al. Cytogenetics of human meningiomas: an analysis of 125 cases [abstract]. Cancer Genet Cytogenet 1992;63:174.
22. Ichikawa D, Hashimoto N, Hoshima M, Yamaguchi T, Sawai K, Nakamura Y, et al. Analysis of numerical aberrations in specific chromosomes by fluorescence in situ hybridization (FISH) as a diagnostic tool in breast cancer. Cancer 1996;71: 2064-9.